Human Gut Microbiota in Health and Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 62, Issue 2, 2018, Pages 549-560

  Szablewski, Leszek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Alzheimer's disease; dysbiosis; gut microbiota; metabolic endotoxemia; physiology

Indexed keywords

ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT;

ALZHEIMER DISEASE; DYSBIOSIS; ENDOTOXEMIA; HUMAN; INTESTINE FLORA; LIPID DIET; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK; SPECIES COMPOSITION; GASTROINTESTINAL TRACT; MICROBIOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

ALZHEIMER DISEASE; DIET, HIGH-FAT; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; RISK FACTORS;

EID: 85043594463     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-170908     Document Type: Review

References (143)

1. Tilg H, Moschen AR (2014) Microbiota and diabetes: An evolving relationship. Gut 63, 1513-1521.
2. Ley RE, Peterson DA, Gordon JI (2006) Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848.
3. Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214.
4. Schroeder BO, Bäckhed F (2016) Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 22, 1079-1089.
5. Munoz-Garach A, Diaz-Perdigones C, Tinahones FJ (2016) Gut microbiota and type 2 diabetes mellitus. Endocrinol Nutr 63, 560-568.
6. Sekirov I, Russel SL, Antunes CM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90, 859-904.
7. Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuno MI (2014) Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol 6, 190.
8. Koboziev I,Webb CR, Furr KL, GrishamMB(2014) Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med 68, 122-133.
9. Dominiguez-Bello MG, Costello EK, Contreras M, Margris H, Hidalgo G, Fierer N, Knight R (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107, 11971-11975.
10. Zetendal EG, Rajilic-Stojanovic M,VosWM(2008) Highthroughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615.
11. Makino H, Kushiro A, Ishikawa E, Kubota H, Gawad A, Sakai T, Oishi K, Martin R, Ben-Amor K, Knol J, Tanaka R (2013) Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS One 8, e78331.
12. Munyaka PM, Khafipour E, Ghala JE (2014) External influence of early childhood establishment of gut microbiota and subsequent health implications. Font Pediatr 2, 109.
13. Pozo-Rubio T, Mujico JR, Marcos A, Puertollano E, Nadal I, Sanz Y, Nova E (2011) Immunostimulatory effect of faecal Bifidobacterium species of breast-fed and formulafed infants in a peripheral blood mononuclear cell/Caco-2 co-culture system. Br J Nutr 106, 1216-1223.
14. Benno Y, Sawada K, Mitsuoka T (1984) The intestinal microflora of infants: Composition of fecal flora in breast-fed and bottle-fed infants. Microbial Immunol 28, 975-986.
15. De Fillippo C, Cavalieri D, Di Paola M, Ramazotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107, 14691-14696.
16. Oriach CS, Robertson RC, Santon C, Cryan JF, Dinan TG (2016) Food for thought: The role of nutrition in the microbiota-gut-barrier-axis. Clin Nutr Exp 6, 25-38.
17. Walsh CJ, Guinane CM, O'Toole PW, Cotter PD (2014) Beneficial modulation of the gut microbiota. FEBS Lett 588, 4120-4130.
18. Cleasson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O'Sullivan O, Fitzgerald GF, Deane J, O'Connor M, Harnedy N, O'Connor K, O'Mahony D, van Sinderen D, Wallace M, Brennan L, Stanton C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Ross RP, O'Toole PW (2012) Gut Microbiota composition correlates with diet and health in the elderly. Nature 488, 178-184.
19. Jernberg C, Löfmark S, Edlung C, Jansson JK (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156, 3216-3223.
20. Dethlefsen L, RelmanDA(2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108, 4554-4561.
21. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummerling I, van den Brandt PA, Stobberingh EF (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511-521.
22. Murphy EF, Cotter PD, Hogan A, O'Sullivan O, Joyce A, Fouchy F, Clarke SF, MarguesTM,O'TollePW, Stanton C, Quigley EM, Daby C, Ross PR, O'Doherty RM, Shanahan F (2013) Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62, 220-226.
23. Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6, 2383-2400.
24. McFarland LV(2008) Antibiotic-associated diarrhea: Epidemiology, trends and treatments. Future Microbiol 3, 563-578.
25. Hviid A, Svanstrom H (2009) Antibiotic use and intussusception in early childhood. J Antimicrobiol Chemother 64, 642-648.
26. Iapichino G, Callegari ML, Marzorati S, Cigada M, Corbella D, Ferrari S, Morelli L (2008) Impact of antibiotics on the gut microbiota of critically ill patients. J Med Microbiol 57, 1007-1014.
27. Pineiro M, Stanton C (2007) Probiotic bacteria: Legislative framework-requirements to evidence basis. J Nutr 137, 850S-853S.
28. Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Pedersen HK, Arumugam M, Kristiansen K, Voigt AY, Vestergaard K, Henog R, Costea PI, Kultima JR, Li J, Jørgsen T, Levenez F, Dore J, consortium MetaHIT, Nielsen HB, Brunak S, Raes J, Hansen T,Wang J, Ehrlich SD, Bork P, Pedersen O (2015) Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262-266.
29. Wu H, Esteve E, Tremaroli V, Khan MT, Cesar R, Mannerås-Holm L, Ståhlman M, Olsson LM, Planas-Felix M, Xifra G, Mercader JM, Torrents D, Burcelin R, Ricart W, Perkins R, Fernandez-Real JM, Bäckhed F (2017) Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med 23, 850-858.
30. Chapman C, Gibson G, Rowland I (2011) Health benefits of probiotics: Are mixtures more effective than single strains. Eur J Nutr 50, 1-17.
31. Pokrzywnicka P, Gumprecht J (2016) Intestinal microbiota and its relationship with diabetes and obesity. Clin Diabetol 5, 164-172.
32. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C,Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772.
33. Yadov H, Jain S, Sinha PR (2007) Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23, 62-68.
34. Gibson GR, RoberfroidMB(1995) Dietary modulation of the human colonic microbiota; introducing the concept of prebiotics. J Nutr 125, 1401-1412.
35. Meyer D, Stasse-WolthuisM(2009) The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr 125, 1277-1289.
36. Davis L, Martínez I,Walter J, Goin C, Hutkins RW(2011) Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One 6, e25200.
37. Strowski MZ, Wiedenmann B (2009) Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases. Gut 58, 1044-1045.
38. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R (2008) Changes in gut microbiota, metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481.
39. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90, 1236-1243.
40. Queipo-Ortuno MI, Bodo-Ordoónez M, Muri M, Gomez-Zumaguero JM, Clemente-Postigo M, Estruch R, Cardona Diaz F, Andrés-Lacueva C, Tinahones FJ (2012) Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr 95, 1323-1334.
41. Clemente-Postigo M, Queipo-Ortuno MI, Bodo-Ordonez M, Coin-Aragüez L, Roca-Rodriguez MM, Delgado-Lista J, Cardona F, Andres-Lacueva C, Tinahones FJ (2013) Effect of acute and chronic red wine consumption on lipopolysaccharide concentrations. Am J Clin Nutr 97, 1053-1061.
42. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM (2007) Selective increases of bifidobacterial in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxemia. Diabetologia 50, 2374-2383.
43. Erridge C, Attina T, Spickett CM,Webb DJ (2007)Ahighfat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86, 1286-1292.
44. Creely SJ, McTernan PG, Kusminski CM, Fisher FM, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292, E740-E747.
45. Cani PD, Delzenne NM (2009) The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 15, 1546-1558.
46. Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A (2014) Gut microbiota and metabolic syndrome. World J Gastroenterol 20, 16079-16094.
47. Turnbaugh PJ, Hamady M, Yatsunenko T, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gorfon JL (2009) A core gut microbiome in obese and lean twins. Nature 457, 480-484.
48. Musso G, Gambino R, Cassader M (2010) Obesity, diabetes and gut microbiota. The hygiene hypothesis expanded? Diabetes Care 33, 2270-2284.
49. Kaur N, Chen CC, Luther J, Kao JY (2011) Intestinal dysbiosis in inflammatory bowel disease. Gut Microbes 2, 211-216.
50. Allin KH, Nielsen T, Pedersen O (2015) Gut microbiota in patients with type 2 diabetes. Eur Endocrinol 172, R167-R177.
51. Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M (2016) The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis 15, 108.
52. Munro N (2016) Gut microbiota: Its role in diabetes and obesity. Diab Primary Care 18, 1-6.
53. Wang L, ChristophersenCT, Sorich MJ, Gerber JP, Angley MT, Conlon MA (2011) Low relative abundances of the mucolytic bacterium Ackermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl Environ Microbiol 77, 6718-6721.
54. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK (2013) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451-1463.
55. Dickerson FB, Stallings C, Origoni A, Katsafans E, Savage CL, Schweinfurth LA, Goga J, Khushalani S, Yolken RH (2014) Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: A randomized, placebo-controlled trial. Prim Care Companion CNS Disord 16, pii: PCC. 13m01579.
56. Jiang H, Liang Z, Zhang Y, Mao H,Ma Z, Yin Y,WangW, Tang W, Tan Z, Shi J, Li L, Ruan B (2015) Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 48, 186-194.
57. Belkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157, 121-141.
58. Jiang C, Li G, Huang P, Liu Z, Zhao B (2017) The gut microbiota and Alzheimer's disease. J Alzheimers Dis 58, 1-15.
59. Mulak A, Bonaz B (2015) Brain-gut-microbiota axis in Parkinson's disease. World J Gastroenterol 21, 10609-10620.
60. Wang B, Yao M, Lv L, Ling Z, Li L (2017) The human microbiota in health and disease. Engineering 3, 71-82.
61. Clark A, MachN(2016) Exercise-induced stress behavior, gut-microbiota-brain axis and diet: A systemic review for athletes. J Int Soc Sports Nutr 13, 43.
62. Ceni MC, Sanz Y, Codoner-Franch P (2017) Influence of gut microbiota on neuropsychiatric disorders. World J Gastroenterol 23, 5486-5498.
63. Falluca F, Porrata C, Falluca S, Pianesi M (2014) Influence of diet on gut microbiota, inflammation and type 2 diabetes. First experience with macrobiotic Ma-Pi 2 diet. Diabet Metab Res Rev 30(Suppl 1), 48-54.
64. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ (2006) Colonic health: Fermentation and short chain fatty acids. J Clin Gastroenterol 40, 235-243.
65. Duncan SH, Louis P, Thomson JM, Flint HJ (2009) The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 11, 2112-2122.
66. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, JakobsenM(2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLos One 5, e9085.
67. Shanahan F, Murphy E (2011) The hybrid science of diet, microbes, and metabolic health. Am J Clin Nutr 94, 1-2.
68. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, Hammer RE, Williams SC, Crowley J, Yanagisawa M, Gordon JL (2008) Effects of gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A 105, 16767-16772.
69. Brahe LK, Astrup A, Larsen IH (2013) Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases? Obes Rev 14, 950-959.
70. De Vadder F, Kovatchva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Bäckked F, Mithieux G (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84-96.
71. Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM (2013) Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 5, 178ra41.
72. Sonnenburg JL, Bäckhed F (2016) Diet-microbiota interactions as mediators of human metabolism. Nature 235, 56-64.
73. Thorburn AN, McKenzie CI, Shen S, Stanley D, Macia L, Mason LJ, Roberts LK, Wong CH, Shim R, Robert R, Chevalier N, Tan JK, Marino E, Moore RJ, Wong L, McConville MJ, Tull DJ, Wood LG, Murphy VE, Mattes J, Gibson PG, Mackay CR (2015) Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun 6, 7320.
74. Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr 133, 2485S-2493S.
75. Schilderink R, Verseijden C, de Jonge WJ (2013) Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Front Immunol 4, 226.
76. Atarashi K, Tanoue T, Shima T, Imaoko A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanow II, Umesaki Y, Itoh K, Honda K (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Nature 331, 337-341.
77. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schiller HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282-1286.
78. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland MC (1998) Functional food science and gastrointestinal physiology and function. Br J Nutr 80(Suppl 1), S147-S171.
79. Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJ, de Boer JD, Hoogendijk AJ, de Beer R, de Vos A, Belzer C, de Vos WM, van der Poll T, Wiersinga WJ (2016) The gut microbiota plays a protective role in the host defense against pneumococcal pneumonia. Gut 65, 575-583.
80. Thomas C, Gioiello A, Noriega I, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M, Pellicciari R, Auwerx J, Schoonjans K (2009) TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 10, 167-177.
81. Midtvedt T (1974) Microbial bile acid transformation. Am J Clin Nutr 27, 1341-1347.
82. Kawamata Y, Fujii R, Hosova M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y, Hinuma S, Fujisawa Y, Fujino M (2003) A G proteincoupled receptor responsive to bile acids. J Biol Chem 278, 9435-9440.
83. Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17, 225-235.
84. Barrett E, Ross R, O'Toole P, Fitzgerald G, Stanton C (2012)-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 113, 411-417.
85. Reigstad CS, Salmonson CE, Rainey JF, Szurszewski JH, Linden DR, Sonnenberg JL, Farrugia G, Kashyao PC (2015) Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J 29, 1395-1403.
86. Cryan JF, Dinan TG (2012) Mind-altering microorganisms: The impact of the gut microbiota on brain and behavior. Nat Rev Neurosci 13, 701-712.
87. Liu X, Cao S, Zhang X (2015) Modulation of gut microbiota-brain axis by probiotics, prebiotics and diet. J Agric Food Chem 63, 7885-7895.
88. Galland L (2014) The gut microbiome and the brain. J Med Food 17, 1261-1272.
89. Rieder R, Wisniewski PJ, Alderman BL, Campbell SC (2017) Microbes and mental health:Areview. Brain Behav Immun 66, 9-17.
90. Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, TheoharidesTC(2015) Gut-microbiota-brain axis and effect on neuropsychiatric disorders with suspected immune dysregulation. Clin Ther 37, 984-995.
91. Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K (2014) Gut microbes and the brain: Paradigm shift in neuroscience. J Neurosci 34, 15490-15496.
92. Mayer EA, Tillish K, Gupta A (2015) Gut/brain axis and the microbiota. J Clin Invest 125, 926-938.
93. Leung K, Thuret S (2015) Gut microbiota: A modulator of brain plasticity and cognitive function in ageing. Healthcare 3, 898-916.
94. Budzyński J, Kłopocka M (2014) Brain-gut axis in the pathogenesis of Helicobacter pylori infection. World J Gastroenterol 20, 5212-5225.
95. Cani PD, Knauf C (2016) How gut microbiota talk to organs: The role of endocrine and nervous routes. Mol Metab 5, 743-752.
96. Van Cauwenberghe C, Van Braeckhoven C, Sleegers K (2015) The genetic landscape of Alzheimer disease: Clinical implications and perspectives. Gen Med 18, 421-430.
97. Chakrabarti S, Khemka VK, Banerjee A, Chatterjee G, Ganguly A, BiswasA(2015) Metabolic risk factors of sporadic Alzheimer's disease: Implications in the pathology, pathogenesis and treatment. Aging Dis 6, 282-299.
98. Chu LW(2012) Alzheimer's disease: Early diagnosis and treatment. Hong Kong Med J 18, 228-237.
99. Sun X, Chen W, Wang Y (2015)-Amyloid: The key peptide in the pathogenesis of Alzheimer's disease. Front Pharmacol 6, 1-9.
100. Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7, 137-152.
101. Zhang H, Ma Q, Zhang YW, Hu H (2012) Proteolytic processing of Alzheimer's-amyloid precursor protein. J Neurochem 120, 9-21.
102. Alexandrov PN, Pogue A, Bhattacharjee S, Lukiw WJ (2011) Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease. Neuroreport 22, 623-627.
103. O'Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 34, 185-204.
104. Bhattacharjee S, Lukiw WJ (2013) Alzheimer's disease and the microbiome. Front Cell Neurosci 7, 153.
105. Hill JM, Bhattacharjee S, Pogue AI, Lukiw WJ (2014) The gastrointestinal tract microbiome and potential link to Alzheimer's disease. Front Neurol 5, 1-4.
106. Lanctot KL, Herrmann N, Mazzotta P, Khan LR, Ingber N (2004) GABAergic function in Alzheimer's disease: Evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. Can J Psychiat 49, 439-453.
107. Solas M, Puerta E, Ramirez MJ (2015) Treatment options in Alzheimer's disease: The GABA story. Curr Pharm 21, 4960-4971.
108. Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161, 264-276.
109. Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A, Hayreh D, D'Angelo G, Benzinger T, Yoom H, Kim J, Morris JC, MintunMA,Sheline YJ (2011) Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A 108, 14968-14973.
110. Lakhan SE, Caro M, Hadzimichalis N (2013) NMDA receptor activity in neuropsychiatric disorders. Front Psychiatry 4, 52.
111. Neufeld KM, Kang N, Bienestack J, Foster JA (2011) Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 23, 255-264.
112. Wang T, Hu X, Liang S, Li W, Wu X, Wang L, Jin F (2015) Lactobacillus fermentum restores the antibiotic induced physiological and psychological abnormalities in rats. Benef Microbes 6, 707-717.
113. Schwartz K, Boles BR (2013) Microbial amyloids-functions and interactions within the host. Curr Opin Microbiol 16, 93-99.
114. Mulligan VK, Chakrabartty A (2013) Protein misfolding in the late-onset neurodegenerative diseases: Common themes and the unique case of amyotrophic lateral sclerosis. Proteins 81, 1285-1303.
115. Cox PA, Davis DA, Mash DC, Metcalf JS, Banack SA (2016) Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain. Proc Biol Sci 283, 20152397.
116. Brenner SR (2013) Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as beta-N-methylamino-L-alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson-Dementia-Complex in humans and equine motor neuron disease in horses. Med Hypotheses 80, 103-108.
117. Hu X, Wang T, Jin F (2013) Alzheimer's disease and gut microbiota. Sci China Life Sci 59, 1006-1023.
118. Gareau MG,Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, Mac Quen G, Sherman PM (2011) Bacterial infection causes stress-induced memory dysfunction in mice. Gut 60, 307-317.
119. ClarkeG, Grenham S, Scully P, Fitzgerald P, Moloney RD, Stanhan F, Dinan TG, Cryan JF (2013) The microbiomegut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18, 666-673.
120. Diez Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S (2011) Normal gut microbiota modulates brain development and behavior. Pro Natl Acad Sci U S A 108, 3047-3052.
121. Carlino D, De Vanna M, Tongiorgi E (2013) Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions? Neuroscientist 19, 345-353.
122. Hill JM, Lukiw WJ (2015) Microbial-generated amyloids and Alzheimer's disease (AD). Front Aging Neurosci 7, 9.
123. Gerald HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, Frey WH, Bordayo EZ, Whittum-Hudson JA, Hudson AP (2006) Chlamydiophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol 48, 355-366.
124. Kountouras J, Boziki M, Zavos C, Gavalas E, Giartza-Taxidou E, Venizelos I, Deretzi G, Grigoriadis N, Tsiaousi E, Vardaka E (2012) A potential impact of chronic Helicobacter pylori infection on Alzheimer's disease pathology and course. Neurobiol Aging 33, e3-e4.
125. Kountouras J, Gavalas E, Zavos C, Stergiopoulos C, Chatzopouloc C, Kapetanakis N, GisakisD(2007) Alzheimer's disease and Helicobacter pylori infection: Defective immune regulated and apoptosis as proposed common links. Med Hypotheses 68, 368-388.
126. Prandota J (2014) Possible link between toxoplasma gondii and the anosmia associated with neurodegenerative diseases. Am J Alzheimers Dis 29, 205-214.
127. Ball MJ (1982) Limbic predilection in Alzheimer dementia: Is relative herpes virus involved. Can J Neurol 9, 303-306.
128. Wozniak MA, Mee AP, Itzhaki RF (2009) Herpes simplex virus type 1 DNA is located within Alzheimer's amyloid plaques. J Pathol 217, 131-138.
129. Widera M, Klein AN, Cinar Y, Funke SA, Willbold D, Schaal H (2014) The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity. AIDS Res Ther 11, 1.
130. Lurain NS, Hanson BA, Martinson J, Leurgans SE, Landay AL, BennettDA, Schneider JA(2013)Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis 208, 564-572.
131. Chiu WC, Tsan YT, Tsai SL, Chang CJ, Wang JD, Chen PC, Health Data Analysis in Taiwan Research Group (2014) Hepatitis C viral infection and the risk of dementia. Eur J Neurol 21, 1068-e59.
132. Bonfili L, Cecarini V, Berardi S, Scarpona S, Suchodolski JS, Nasuti C, Fiorini D, BoarelliMC,Rossi G, EleuteriAM (2017) Microbiota modulation counteracts Alzheimer's disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep 7, 2426.
133. Zhang C, Li S, Yang L, Huang P, Li W, Wang S, Zhao G, Zhang M, Pang X, Yan Z, Liu Y, Zhao L (2013) Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun 4, 2163.
134. Kim MS, Hwang SS, Park EJ, Bae EJ (2013) Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation. Environ Microbiol Rep 5, 765-775.
135. Zimmer J, Lange B, Frick JS, Sauer H, Zimmermann K, Schwiertz A, Rusch K, Klosterhalfen S, Enck P (2012) A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 66, 53-60.
136. de La Serre CB, Ellis C, Lee J, Hartman AL, Rutledge JC, Raybould HE (2010) Prosperity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299, G440-G448.
137. Chen D, Yang Z, Chen X, Huang Y, Yin B, Guo F, Zhao H, Huang J, Wu Y, Gu R (2014) Effect of Lactobacillus rhamnosus hsryfm 1301 on the intestinal microbiota of a hyperlipidemic rat model. BMC Complement Altern Med 14, 386.
138. Kim KA, Gu W, Lee IA, John EH, Kim DH (2012) High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One 7, e47713.
139. Hamilton MK, Boudry G, Lemay DG, Raybould HE (2015) Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol 308, G840-G851.
140. Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopadhya I (2014) Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years? World J Gastroenterol 20, 1192-1210.
141. Parashar A, Udayabahanu M (2017) Gut microbiota: Implications in Parkinson's disease. Parkin Rel Dis 38, 1-7.
142. RosenfeldCS(2015) Microbiome disturbances and autism spectrum disorders. Drug Metab Dispos 43, 1557-1571.
143. Russel DW (2003) The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 72, 137-174.